Mushrooms seem to be popping up everywhere these days.
All as millions digest the idea that mushrooms can support immune systems, reduce inflammation, and help improve moods. Chaga for example has even caught the attention to coffee drinkers, says Thrillist. “ It’s a superfood said to prevent and slow cancer, reduce inflammation, lower blood pressure and sugar, promote immunity, and even allay the side effects of drugs. Short term, it offers stress relief, stimulates cognitive function, and elevates athletic endurance.”
That’s great news for companies involved with mushrooms, including NeonMind Biosciences Inc. (CSE:NEON) (OTC:NMDBF), ATAI Life Sciences (NASDAQ:ATAI), Compass Pathways (NASDAQ:CMPS), Mydecine Innovations Group Inc. (NEO:MYCO) (OTC:MYCOF), and Cybin Inc. (NEO:CYBN)(OTC:CLXPF).
In addition, according to The Food Institute, “Supplements, extracts, and protein powders from mushrooms, including chaga, lion’s mane, reishi, and shiitake continue to grow in popularity. Functional beverage offerings that incorporate these supplements, such as mushroom coffee, are also expanding.”